Anonymous ID: b0c668 Sept. 12, 2021, 10:10 p.m. No.14568788   🗄️.is đź”—kun   >>8827

NEW ZEALAND DATA SHEET

  1. PRODUCT NAME

COMIRNATY™ COVID-19 VACCINE 0.5 mg/mL concentrated suspension for injection.

  1. QUALITATIVE AND QUANTITATIVE COMPOSITION

This is a multidose vial and must be diluted before use.

One vial (0.45 mL) contains 6 doses of 0.3 mL after dilution, see Section 4.2 Dose and method

of administration and Section 6.6 Special precautions for disposal and other handling.

1 dose (0.3 mL) contains 30 micrograms of BNT162b2 [mRNA] (embedded in lipid

nanoparticles).

The active ingredient is a single-stranded, 5’-capped messenger RNA (mRNA) produced using

a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral

spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

For the full list of excipients, see Section 6.1 List of excipients.